Faecal Immunochemical Testing (FIT) to provide support for patients identified with symptoms associated with bowel cancer. (Великобритания (Англия, Шотландия, Уэльс) - Тендер #41502772) | ||
| ||
| Для перевода текста тендера на нужный язык воспользуйтесь приложением: | ||
Страна: Великобритания (Англия, Шотландия, Уэльс) (другие тендеры и закупки Великобритания (Англия, Шотландия, Уэльс)) Организатор тендера: NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) Номер конкурса: 41502772 Дата публикации: 05-05-2023 Источник тендера: Государственные закупки Уэльса (часть Соединённого Королевства Великобритании и Северной Ирландии) |
||
| Title: | Faecal Immunochemical Testing (FIT) to provide support for patients identified with symptoms associated with bowel cancer. |
| OCID: | ocds-kuma6s-110036 |
| Published by: | NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) |
| Authority ID: | AA0221 |
| Publication Date: | 05/05/2023 |
| Deadline Date: | |
| Deadline Time: | |
| Notice Type: | 03 Contract Award Notice - Successful Supplier(s) |
| Has Documents: | No |
| Has SPD: | No |
| Abstract: |
The provision of goods and services to support faecal immunochemical testing (FIT) from Alpha Laboratories to support All Wales testing for patients identified in primary and secondary
care as having symptoms associated with bowel cancer. CPV: 33696500, 33696500. |
Results of the procurement procedure
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
4-5 Charnwood Court,, Heol Billingsley, Parc Nantgarw
Cardiff
CF15 7QZ
UK
Telephone: +44 1443848585
E-mail: shannon.mason@wales.nhs.uk
NUTS: UK
Internet address(es)
Main address: http://nwssp.nhs.wales/ourservices/procurement-services/
Address of the buyer profile: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221
Body governed by public law
Health
Faecal Immunochemical Testing (FIT) to provide support for patients identified with symptoms associated with bowel cancer.
Reference number: PHW-STA-555
II.1.2) Main CPV code33696500
II.1.3) Type of contractSupplies
II.1.4) Short descriptionThe provision of goods and services to support faecal immunochemical testing (FIT) from Alpha Laboratories to support All Wales testing for patients identified in primary and secondary care as having symptoms associated with bowel cancer.
II.1.6) Information about lotsThis contract is divided into lots: No
II.1.7) Total value of the procurementValue excluding VAT: 298 880.00 GBP
33696500
II.2.3) Place of performanceNUTS code:
UKL
Main site or place of performance:
Public Health Wales, NHS Trust.
II.2.4) Description of the procurementThe provision of goods and services to support faecal immunochemical testing (FIT) from Alpha Laboratories to support All Wales testing for patients identified in primary and secondary care as having symptoms associated with bowel cancer.
NHS Wales Shared Service Partnership on behalf of Public Health Wales NHS Trust wish to inform the market that due to consequences of the global pandemic, Covid-19, they are awarding a contract for the provision of goods and services to support Faecal Immunochemical Testing (FIT) from Alpha Laboratories to support All Wales testing for patients identified in primary and secondary care as having symptoms associated with bowel cancer.
The existing Bowel Screen Wales contract with Alpha Laboratories for Provision of Faecal Immunochemical Testing Analysers and Consumables was due to end in November 2021, and it was intended to go to market for the supply of Symptomatic and Screening Fit as one tender.
However, due to the outbreak of Covid-19 in 2020 and the subsequent suspension of routine hospital services and Screening across Wales; The Screening Division was approached to provide testing for patients presenting in Primary/Secondary care with symptoms of bowel cancer. Prior to Covid-19 these patients would be referred to Endoscopy. To ensure that urgent suspected cancers were identified during the pandemic, the decision was made to utilise Screenings existing FIT testing capability and service model.
To establish this service at short notice, the Screening Laboratory have entered contract with Alpha, the primary supplier of FIT to the Bowel Screening Wales Programme.
Appointing Alpha Laboratories as the single supplier was the most considered and beneficial approach to deliver the service and support the wider NHS needs in Wales. Due to the existing MSC arrangements in place with Alpha Laboratories for FIT Screening, the choice of this supplier would ensure: - Continuity of supply. - Compatibility with existing equipment and testing methodologies. - Reduced need for training - Existing patient material can be used to ensure patients complete their test correctly.
The Public Health Wales Screening Division do not have the resources to undertake a competitive procurement process through an open OJEU procedure currently due to supporting various screening and Covid activity.
In order to enable the provision of the Faecal Immunochemical Testing (FIT), to support all Wales testing for patients identified as having symptoms associated with bowel cancel, Public Health Wales would like to inform the market that under Regulation 32 (2) (C)of the Public Contracts Regulation 2015(PCR’s) as detailed in UK Government guidance PPN01/20 they are awarding the contract to Alpha Laboratories. The trust has met the criteria for awarding a contract under this regulation due to the disruption to patient care and services that COVID-19 poses to the population of Wales.
II.2.5) Award criteriaPrice
II.2.11) Information about optionsOptions: No
II.2.13) Information about European Union fundsThe procurement is related to a project and/or programme financed by European Union funds: No
II.2.14) Additional informationAligning the FIT symptomatic workload with the contract already in place for the FIT screening is the only practical option to provide continued patient care. Going forward, both elements will be combined in the procurement of the existing contract for renewal.
Award of a contract without prior publication of a call for competition
Justification for selected award procedure:
The procurement falls outside the scope of application of the Directive
Explanation
In order to enable the provision of the Faecal Immunochemical Testing (FIT), to support all Wales testing for patients identified as having symptoms associated with bowel cancel, Public Health Wales would like to inform the market that under Regulation 32 (2) (C)of the Public Contracts Regulation 2015(PCR’s) as detailed in UK Government guidance PPN01/20 they are awarding the contract to Alpha Laboratories. The trust has met the criteria for awarding a contract under this regulation due to the disruption to patient care and services that COVID-19 poses to the population of Wales.
IV.1.8) Information about Government Procurement Agreement (GPA)The procurement is covered by the Government Procurement Agreement: Yes
Notice number in the OJ S:
2021/S 000-008738
Contract No: PHW-STA-555
A contract/lot is awarded: Yes
01/04/2021
V.2.2) Information about tendersNumber of tenders received: 1
Number of tenders received from SMEs: 0
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 1
Number of tenders received by electronic means: 1
The contract has been awarded to a group of economic operators: No
V.2.3) Name and address of the contractorAlpha Laboratories Ltd
40 Parham Drive, Eastleigh
Hampshire
SO504NU
UK
Telephone: +44 02380487239
NUTS: UKJ3
The contractor is an SME: No
V.2.4) Information on value of the contract/lot (excluding VAT)Total value of the contract/lot: : 298 880.00 GBP
V.2.5) Information about subcontracting(WA Ref:131351)
High Court
Royal Courts of Justice, The Strand
London
WC2A 2LL
UK
Telephone: +44 2079477501
VI.4.3) Review procedurePrecise information on deadline(s) for review procedures:
NHS Wales Shared Services Partnership on behalf of Public Health Wales Trust will allow a minimum 10 calendar day standstill period between notifying the award decision and awarding the contract.
05/05/2023
Information added to the notice since publication.
Additional information added to the notice since it"s publication.| No further information has been uploaded. |
| Main Contact: | shannon.mason@wales.nhs.uk |
| Admin Contact: | N/a |
| Technical Contact: | N/a |
| Other Contact: | N/a |
| ID | Title | Parent Category |
|---|---|---|
| 33696500 | Laboratory reagents | Reagents and contrast media |
| ID | Description |
|---|---|
| 1017 | Bridgend and Neath Port Talbot |
| 1022 | Cardiff and Vale of Glamorgan |
| 1015 | Central Valleys (Merthyr Tydfil, Rhondda Cynon Taf) |
| 1013 | Conwy and Denbighshire |
| 1020 | East Wales |
| 1023 | Flintshire and Wrexham |
| 1016 | Gwent Valleys (Torfaen, Blaenau Gwent, Caerphilly) |
| 1012 | Gwynedd |
| 1011 | Isle of Anglesey |
| 1021 | Monmouthshire and Newport |
| 1024 | Powys |
| 1014 | South West Wales (Carmarthenshire, Pembrokeshire, Ceredigion) |
| 1018 | Swansea |
| 1000 | WALES |
| 1010 | West Wales and The Valleys |
The buyer has restricted the alert for this notice to suppliers based in the following regions.
Alert Region Restrictions| There are no alert restrictions for this notice. |
| Hide related notices | |
| APR362923: Faecal Immunochemical Testing (FIT) to provide support for patients identified with symptoms associated with bowel cancer. | |
| Publication Date: | 23/04/2021 |
| Notice Type: | 15 Voluntary ex ante Transparency (VEAT) Notice |
| Authority name: | NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) |
| MAY436496: Faecal Immunochemical Testing (FIT) to provide support for patients identified with symptoms associated with bowel cancer. | |
| Publication Date: | 05/05/2023 |
| Notice Type: | 03 Contract Award Notice - Successful Supplier(s) |
| Authority name: | NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) |